Hassan, M.A.; Elmageed, G.M.A.; El-Qazaz, I.G.; El-Sayed, D.S.; El-Samad, L.M.; Abdou, H.M.
The Synergistic Influence of Polyflavonoids from Citrus aurantifolia on Diabetes Treatment and Their Modulation of the PI3K/AKT/FOXO1 Signaling Pathways: Molecular Docking Analyses and In Vivo Investigations. Pharmaceutics 2023, 15, 2306.
https://doi.org/10.3390/pharmaceutics15092306
AMA Style
Hassan MA, Elmageed GMA, El-Qazaz IG, El-Sayed DS, El-Samad LM, Abdou HM.
The Synergistic Influence of Polyflavonoids from Citrus aurantifolia on Diabetes Treatment and Their Modulation of the PI3K/AKT/FOXO1 Signaling Pathways: Molecular Docking Analyses and In Vivo Investigations. Pharmaceutics. 2023; 15(9):2306.
https://doi.org/10.3390/pharmaceutics15092306
Chicago/Turabian Style
Hassan, Mohamed A., Ghada M. Abd Elmageed, Ibtehal G. El-Qazaz, Doaa S. El-Sayed, Lamia M. El-Samad, and Heba M. Abdou.
2023. "The Synergistic Influence of Polyflavonoids from Citrus aurantifolia on Diabetes Treatment and Their Modulation of the PI3K/AKT/FOXO1 Signaling Pathways: Molecular Docking Analyses and In Vivo Investigations" Pharmaceutics 15, no. 9: 2306.
https://doi.org/10.3390/pharmaceutics15092306
APA Style
Hassan, M. A., Elmageed, G. M. A., El-Qazaz, I. G., El-Sayed, D. S., El-Samad, L. M., & Abdou, H. M.
(2023). The Synergistic Influence of Polyflavonoids from Citrus aurantifolia on Diabetes Treatment and Their Modulation of the PI3K/AKT/FOXO1 Signaling Pathways: Molecular Docking Analyses and In Vivo Investigations. Pharmaceutics, 15(9), 2306.
https://doi.org/10.3390/pharmaceutics15092306
